Literature DB >> 7555145

Adverse pulmonary effects of mesalamine.

A Muzzi, F Ciani, D Bianchini, G Festini, C Volpe.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7555145     DOI: 10.1378/chest.108.4.1181-a

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  6 in total

1.  Mesalamine-induced Pneumonitis and Serum Sickness-like Reaction.

Authors:  Adam Harris; Shanti Eswaran; Brian Bosworth; Maya Gambarin-Gelwan; Ellen J Scherl
Journal:  Gastroenterol Hepatol (N Y)       Date:  2007-11

2.  Mesalazine-induced bronchiectasis and eosinophilia in a patient with ulcerative colitis: a case report.

Authors:  L C Price; A Poullis; S Grubnic; J Y Kang; C F J Rayner
Journal:  J R Soc Med       Date:  2007-03       Impact factor: 5.344

3.  Respiratory distress during mesalamine therapy.

Authors:  M Guslandi
Journal:  Dig Dis Sci       Date:  1999-01       Impact factor: 3.199

4.  Asymptomatic presentation of mesalamine-induced lung injury in an adolescent with Crohn disease.

Authors:  Rafael Cilloniz; Sarah Elizabeth Chesrown; Regino P Gonzalez-Peralta
Journal:  BMJ Case Rep       Date:  2009-03-20

5.  Gastroenterology case report of mesalazine-induced cardiopulmonary hypersensitivity.

Authors:  José Ferrusquía; Isabel Pérez-Martínez; Ricardo Gómez de la Torre; María Luisa Fernández-Almira; Ruth de Francisco; Luis Rodrigo; Sabino Riestra
Journal:  World J Gastroenterol       Date:  2015-04-07       Impact factor: 5.742

6.  A Case of Balsalazide-Induced Limited Form of Granulomatosis with Polyangiitis with Bronchiolitis Obliterans Organizing Pneumonia-like Variant in Ulcerative Colitis.

Authors:  Shin Myung Kang; Young Rock Jang; Hyun-Hwa Yoon; Suji Kim; Eun Young Kim; Seung Yeon Ha; Jeong-Woong Park
Journal:  Tuberc Respir Dis (Seoul)       Date:  2012-03-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.